Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Nicotinic acid derivatives
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Hexopal 1g/5ml oral suspension
0206040AFBCACAC
|
Hexopal | Nicotinic acid derivatives | Cardiovascular System | No data available |
|
Hexopal 500mg tablets
0206040AFBCAAAA
|
Hexopal | Nicotinic acid derivatives | Cardiovascular System | No data available |
|
Hexopal Forte 750mg tablets
0206040AFBCABAB
|
Hexopal | Nicotinic acid derivatives | Cardiovascular System | No data available |
|
Inositol nicotinate 1g/5ml oral suspension
0206040AFAAAHAH
|
Nicotinic acid derivatives | Nicotinic acid derivatives | Cardiovascular System | No data available |
|
Inositol nicotinate 1g/5ml oral suspension sugar free
0206040AFAAACAC
|
Nicotinic acid derivatives | Nicotinic acid derivatives | Cardiovascular System | No data available |
|
Inositol nicotinate 500mg tablets
0206040AFAAAAAA
|
Nicotinic acid derivatives | Nicotinic acid derivatives | Cardiovascular System | No data available |
|
Inositol nicotinate 750mg tablets
0206040AFAAABAB
|
Nicotinic acid derivatives | Nicotinic acid derivatives | Cardiovascular System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.